Roche says did not collude with Novartis to restrict competition
ZURICH, April 10
ZURICH, April 10 (Reuters) - Swiss drugmaker Roche said on Thursday that it had not colluded with Novartis to restrict competition for eye disease treatments.
"Roche confirms there is no agreement between Roche and Novartis that restricts competition," the drugmaker said in a statement.
Earlier on Thursday, the companies said France's competition authority was investigating them on suspicion they were involved in anti-competitive practices in relation to treatment for wet age-related macular degeneration (AMD). (Reporting by Caroline Copley; Editing by Pravin Char)
- China food scandal spreads, drags in Starbucks, Burger King and McNuggets in Japan |
- U.S. courts deliver conflicting rulings on Obama health care law
- Israel pounds Gaza despite international peace efforts |
- EU readies capital, tech sanctions on Russia, but not yet
- Train carrying MH17 bodies on final journey reaches Ukraine city |